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Sonographic features associated with morbidity of chronic
clinical presentations of schistosomiasis mansoni using
the protocol proposed by the World Health Organization*
Aspectos ultrassonográficos associados à morbidade de formas clínicas crônicas de esquistossomose mansônica,
utilizando-se protocolo proposto pela Organização Mundial da Saúde
Daniel Alvarenga Fernandes1, Anny Caroline Porto Chagas2, Amélia Ribeiro de Jesus3, Alex Vianey
Callado França4, Frederico Santana de Lima5, Ângela Maria da Silva6, Atilano Salvador Godinho7,
Karine Garcez Schuster Franco8
Objective: To evaluate sonographic features associated with morbidity in patients with chronic clinical presentations of
schistosomiasis mansoni, according to the protocol proposed by the World Health Organization (WHO). Materials and
Methods: Two distinctive populations were evaluated: a) patients from an endemic area, and b) patients from a tertiary
institution, with histopathologically confirmed periportal fibrosis. Inclusion criteria: diagnosis confirmed by parasitological
stool examination for Schistosoma mansoni (Kato-Katz method). Exclusion criteria: positive serology for HIV, HTLV-1,
HBV or HCV. The Niamey protocol on ultrasonography proposed by the WHO was utilized. Results: As the measures of
periportal spaces were isolatedly evaluated, no alteration was observed in 21% of the tertiary institution patients with
advanced disease. As all parameters of the Niamey protocol were considered, 100% of patients from the tertiary
institution, with severe disease, presented advanced periportal fibrosis. In hepatosplenic patients from endemic areas,
fibrosis was not identified at ultrasonography. Conclusion: The sonographic protocol proposed by the WHO can detect
advanced periportal fibrosis in patients with severe form of disease with higher sensitivity than the isolated measurement
of periportal space. The complexity involved in the sonographic identification of early stages of periportal fibrosis in
endemic areas may give rise to the field of diagnostic supplementation and to a continued improvement of sonographic
protocols in these areas.
Keywords: Schistosomiasis mansoni; Morbidity; Periportal fibrosis; Ultrasonography.
Objetivo: Avaliar aspectos ultrassonográficos associados à morbidade em pacientes com formas clínicas crônicas de
esquistossomose mansônica, utilizando-se protocolo proposto pela Organização Mundial da Saúde (OMS). Materiais
e Métodos: Foram avaliadas duas populações distintas: a) área endêmica e b) institucional terciária, com histopato-
lógico confirmando fibrose. Critérios de inclusão: diagnóstico confirmado por parasitológico de fezes para Schistosoma
mansoni (método Kato-Katz). Critérios de exclusão: sorologia positiva para HIV, HTLV-1, VHB ou VHC. Foi utilizado pro-
tocolo ultrassonográfico de Niamey, proposto pela OMS. Resultados: Avaliando-se isoladamente as medidas dos es-
paços periportais, estas se mostraram sem alterações em 21% dos indivíduos com doença avançada da instituição
terciária. Utilizando-se todos os parâmetros do protocolo, 100% dos indivíduos da instituição terciária, com forma grave
da doença, apresentaram fibrose periportal avançada. Em pacientes hepatoesplênicos da área endêmica não se iden-
tificou fibrose à ultrassonografia. Conclusão: O protocolo ultrassonográfico proposto pela OMS detecta fibrose peri-
portal avançada nos pacientes com forma grave da doença, com maior sensibilidade do que a medida do espaço pe-
riportal isoladamente. A complexidade de identificação das fases iniciais da fibrose periportal, em áreas endêmicas,
pela ultrassonografia, pode suscitar o campo da complementação diagnóstica e a continuidade do aprimoramento
dos protocolos ultrassonográficos nestas áreas.
Unitermos: Esquistossomose mansônica; Morbidade; Fibrose periportal; Ultrassonografia.
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INTRODUCTION
The infection by Schistosoma mansoni
produces four distinctive clinical presenta-
tions: the acute form, and three chronic
forms namely intestinal, hepatointestinal
and hepatosplenic forms. Chronic forms are
most prevalent and more frequently asso-
ciated with morbidity in endemic areas. In
the cases of chronic disease, the morbidity
and mortality are secondary to hepatic fibro-
sis and subsequent portal hypertension(1).
Since the late 1970s, abdominal ultra-
sonography (US) has been utilized in the
assessment of patients with schistosomia-
sis mansoni, demonstrating to be an effi-
cient method in the diagnosis of hepatic
fibrosis(2,3). It has been demonstrated that
the periportal thickening detected at US
corresponds to periportal fibrosis histo-
pathologically found in all cases(1), directly
correlating with the clinical conditions and
risks for complication associated with the
disease(4).
Homeida et al.(5) have graded the peri-
portal thickening at US into four grades,
while Doehring-Schwerdtfeger et al.(6)
have proposed three grades. A third classi-
fication system for periportal thickening in-
tensity at US was proposed by Abdel-
Wahab et al.(7).
The first attempt of standardizing the
performance of US and the analysis of the
method developed by Abdel-Wahab et al.(7)
in the evaluation of schistosomiasis man-
soni morbidity was published in 1992
(Cairo Working Group)(8).
Later, the World Health Organization
(WHO) sponsored a meeting in Niamey,
Niger’s capital city, with the purpose of
standardizing the sonographic classifica-
tion of schistosomal hepatic fibrosis, issu-
ing a publication that was widely accepted
internationally, summarizing the main as-
pects of the method, thus allowing the de-
velopment of comparable morbidity stud-
ies (Niamey Working Group, 2000)(9).
The present study was aimed at evalu-
ating the sonographic findings associated
with morbidity in patients with the chronic
forms of schistosomiasis mansoni from
endemic areas with mild forms of disease,
and in patients selected in a tertiary hospi-
tal, presenting the hepatosplenic form of
disease, utilizing the standardized US pro-
tocol established by the Niamey Working
Group, 2000(9) proposed by WHO.
MATERIALS AND METHODS
A cross-sectional study was undertaken,
evaluating 500 individuals from an en-
demic area municipality (Ilha das Flores,
SE), located in Northern Sergipe State,
Brazil, on the banks of the São Francisco
river. The study was approved by the Com-
mittee for Ethics in Research of the insti-
tution under number CAAE-0022.0.107.
000-08, following the international prin-
ciples on research involving human sub-
jects(10). All the patients have signed a Term
of Free and Informed Consent. The authors
declare that there were no conflicting inter-
ests.
The mentioned population sample was
submitted to parasitological stool test by
means of the Kato-Katz(11) method, with
two samples, three smears each. Out of the
500 individuals from the schistosomiasis
endemic area, 120 patients presented posi-
tive parasitological tests for S. mansoni,
and were submitted to physical examina-
tion. Of those patients, 51 did not undergo
US, either for access difficulties or for their
own choices, and were excluded from the
study. Thus, 69 patients out of the group of
120 individuals with positive parasitologi-
cal tests for S. mansoni, were submitted to
US, comprising the endemic area group.
Also, other 20 patients with the compen-
sated hepatosplenic form of the disease and
histopathologically confirmed periportal
fibrosis were selected among patients com-
ing from clinics of infectology, hepatology
and gastroenterology from a tertiary insti-
tution – Hospital Universitário (HS-HU
group). The patients in this group had not
been submitted to endoscopic or surgical
treatment prior undergoing US.
Inclusion and exclusion criteria were,
respectively, diagnosis confirmed by means
of positive Kato-Katz(11) parasitological
stool test for S. mansoni, and positive se-
rology for HIV, HTLV-1, B or C hepatitis
virus.
Physical examinations included mea-
surements of the liver (below the right cos-
tal margin [RCM] and the xiphoid process)
and spleen (left costal margin) and the in-
dividuals were classified according to the
clinical presentation of schistosomiasis, as
per the clinical classification suggested by
Pessoa and Barros, and modified by Bar-
bosa(12). The intestinal form was defined by
non-palpable liver and spleen; the hepato-
intestinal form, by palpable liver at more
than 3 cm from the RCM, with increased
consistency and non-palpable spleen; and
the hepatosplenic form, by palpable spleen
with normal or increased consistency(12).
A Medison Sonoace 8000 SE apparatus
was utilized in the sonographic studies. All
the US scans were documented by a single
sonographer with a specialist title issued by
Colégio Brasileiro de Radiologia e Diag-
nóstico por Imagem (CBR), with specific
experience and training in US protocols for
schistosomiasis patients. The standard
sonographic sections recommended by the
Niamey Working Group(9) were performed
and the images were later discussed with
another physician with experience in schis-
tosomiasis and knowledgeable on the pro-
tocol, reaching a consensus regarding the
classification. Both investigators were
blinded as regards the clinical presentation
of the disease and patient group (endemic
area or tertiary institution).
The Niamey protocol comprises three
stages, which result into three scores as-
sessing intraparenchymal and periportal
findings as well as portal hypertension (IP,
PT, PH)(9). In this protocol, the assessment
of periportal fibrosis is analyzed by two
different, previously described methods,
namely, a qualitative one (Homeida et al.(5),
Doehring-Schwerdtfeger et al.(6)), which
takes into account the sonographic aspect
of the liver evaluated with basis on char-
acteristic patterns; the IP score in associa-
tion with a quantitative method resulting
from measurements of two or three second
order portal branches, the PT score (Abdel-
Wahab et al.(7)). In combination with those
two criteria, the presence of portal hyper-
tension (PH score) is also analyzed with
basis on indicators of its presence, such as
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measurement of portal vein diameter, pres-
ence of ascites and presence of collateral
circulation. Such scores (IP, PT and PH) are
interpreted by means of a table which clas-
sifies periportal fibrosis as follows: pos-
sible; probable; present; present and ad-
vanced; and present and advanced with
portal hypertension(9). Evaluation by B-
mode US as well as study with color Dop-
pler mapping were performed.
The data analyses were performed with
the GraphPad Prism statistical software.
Analyses of linear correlation were per-
formed between measurements obtained at
US, such as spleen size, right hepatic lobe
size, periportal space and portal vein diam-
eter by calculation of the Spearman’s cor-
relation coefficient. A p < 0.05 value was
considered as being statistically signifi-
cant.
In the schistosomiasis -positive cases,
the patients were treated with a single dose
of praziquantel (40 mg/kg) after the exami-
nations. Other intestinal parasites were
treated with corresponding drugs.
RESULTS
US was performed in 89 individuals, 69
of them coming from endemic areas, with
ages ranging between 18 and 72 years,
mean ± standard deviation (SD) of 49 ±
14.2 years, with 32/69 (46.4%) patients
being men; and 20 patients from Hospital
Universitário (HU) with ages ranging be-
tween 23 and 76 years, mean ± SD of 53 ±
16.9 years, with 8/20 (40.0%) being men.
As regards clinical presentations of the
disease in patients from the endemic area,
classified at physical examination, 42/69
(60.9%) were cases of intestinal presenta-
tion (I); 18/69 (26.1%) hepatointestinal
presentation (HI); and 9/69 (13.0%) hepa-
tosplenic presentation (HS). All the patients
from the HU presented the hepatosplenic
form of the disease.
Figure 1 shows some imaging patterns
observed in the studied patients, where the
qualitative aspect of the hepatic paren-
chyma and the IP score are analyzed ac-
cording to the Niamey Working Group pro-
tocol(9).
Figure 2 shows a sonographic image of
the PT score, which results from the mea-
surement of two or three second order por-
tal branches, i.e., the first segmental branch
deriving from the right or left branch of the
main portal vein.
Figure 3 shows a sonographic image of
the PH score in one of the patients from the
hepatosplenic group (HS-HU), which re-
sults from the analysis of portal hyperten-
sion indicators, such as measurement of the
portal vein diameter, presence of ascites
and presence of collateral circulation. One
observes that the morphological character-
Figure 1. Sonographic images of hepatic parenchyma demonstrating
qualitative patterns with evaluation of the IP score according to the Niamey
Working Group protocol, 2000. A: Pattern D: hyperechogenicity at the
portal bifurcation and main trunk. B: Pattern E: highly echogenic signal
extending from the portal vessels to the parenchyma. C: Pattern F: highly
echogenic bands and strips extending from the main portal vein and its
bifurcation to the periphery of the liver, retracting the surface of the or-
gan.
A B
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ization of the collateral venous circulation
is greatly facilitated at the color Doppler
mapping study.
With the purpose of comparing the
clinical and sonographic classifications
according to the Niamey Working Group,
four groups were formed with basis on
clinical examination: intestinal (I), hepa-
tointestinal (HI), hepatosplenic (HS) and
hepatosplenic HU (HS-HU). Table 1 shows
the distribution of the individuals accord-
ing to clinical presentation and confirma-
tion of fibrosis by US in compliance with
the Niamey classification.
One observes that as the classification
proposed by WHO is adopted, among the
hepatosplenic patients (HS, 9 patients; HS-
HU, 20 patients), 20/29 (68.9%) presented
fibrosis at US, all of them from the HS-HU
group, classified as advanced fibrosis.
Among the 42 individuals classified as pre-
senting the intestinal presentation of dis-
ease, none presented fibrosis at US; among
the 18 patients classified as HI, only three
(16.7%) presented fibrosis at US; and
among the 9 patients classified as HS from
the endemic area, no one presented fibro-
sis at US.
All the patients coming from the tertiary
care institution (HS-HU) presented severe
disease and 100% of them presented ad-
vanced periportal fibrosis characteristic of
schistosomiasis at US utilizing the Niamey
method.
As one isolatedly evaluates the mea-
surements of periportal spaces, the PT
score included as one of the parameters of
the protocol proposed by the WHO and
previously utilized as an isolate parameter
for classifying periportal fibrosis, it is ob-
served that such parameter was unchanged
in all patients from the endemic area with
the hepatosplenic form of disease and in
21% of the individuals with advanced dis-
ease and histopathologically confirmed fi-
brosis (HS-HU).
By analyzing the correlations between
the several measurements performed at US
in patients from the endemic area and from
the tertiary institution (HS-HU), statisti-
cally significant correlations were observed
between portal vein diameter and spleen
size and the measure of the right hepatic
lobe in the HS-HU patients; between por-
tal vein diameter and measure of the peri-
portal space and size of the right hepatic
lobe in patients from the endemic area
(Table 2). No significant correlation was
observed the measurements of the peripor-
tal spaces and any other evaluated param-
eter, even in the HS-HU patients.
DISCUSSION
The prevalence of clinical presentations
of the disease in the present study corrobo-
rates data reported in the literature, which
indicate that the predominant clinical pre-
sentation in endemic areas is the intestinal
one (50.0–70.0%), followed by the hepa-
tointestinal (20.0–40.0%) and the by the
hepatosplenic form (1.0–10.0%)(13). Since
the introduction of the treatment with ap-
Figure 3. Sonographic images demonstrating the PH score. Presence of collateral circulation, visualized
at color Doppler mapping (A) and at B mode (B).
A B
Table 1 Description of clinical presentations of
schistosomiasis determined by clinical examination
and confirmation by ultrasonography of the pres-
ence of portal fibrosis according to the Niamey clas-
sification.
Clinical forms
I
HI
HE
HE-HU
Total
Fibrosis confirmed by US
Yes
0
3
0
20
23
No
42
15
9
0
66
Total
42
18
9
20
89
Figure 2. Sonographic hepatic images demonstrating the quantitative data with evaluation of the IP score,
utilizing the measurement of second order portal branches, i.e., the first segmental branch originating
from the left or right branch of the main portal vein, according to the Niamey Working Group, 2000.
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propriate drugs, a sharp decrease in the rate
of severe forms of schistosomiasis, with the
mild presentation of disease becoming
more frequent(14).
All the patients coming from the ter-
tiary care institution (HS-HU) presented
the severe form of the disease and 100%
of them had advanced hepatic fibrosis
characteristic of schistosomiasis at US
with the Niamey method. Some authors
suggest that such individuals comprise a
classical group of hepatosplenic patients
and correspond to those who seek assis-
tance in reference hospitals because of
bleeding varices(15).
In hepatosplenic patients coming from
the endemic area, fibrosis was not identi-
fied at US. There are reports in the litera-
ture on the difficulty in identifying early
stages of periportal fibrosis, in endemic
areas, by means of US(16). Also, It is con-
sidered that the cause for splenomegaly in
those individuals with little or no fibrosis
at US might be a hyperplastic reaction to
schistosomiasis which would progress with
time to the a severe form of disease, or even
might be caused by other diseases not in-
vestigated in the study. Such aspects are
corroborated by other studies(15,17). Addi-
tionally, one must consider the complexity
involved in the assessment of periportal
thickening(18). Studies indicate magnetic
resonance imaging as the method with the
highest accuracy for the visualization of
periportal thickening at early stages of the
disease, which can be characterized by the
enhancement after paramagnetic contrast
injection(19,20).
As measurements of periportal spaces –
included as one of the parameters of the
Niamey Working Group protocol –, were
isolatedly evaluated, it was observed that
the PT score did not reveal any changes in
all the hepatosplenic patients from the en-
demic area, and also in 21% of the indi-
viduals with advanced disease (HS-HU). In
a different endemic area, De Jesus et al.(14)
have detected different grades of fibrosis in
schistosomal hepatosplenic patients by
means of such measurement, utilized as the
main parameter for the classification of fi-
brosis with a former protocol for US devel-
oped before the definition of that of the
Niamey Working Group (Abdel-Wahab et
al.(7)). In a tertiary institution, Domingues
et al.(21), also utilizing measurements of
periportal spaces, have demonstrated that
all the individuals with the hepatosplenic
form of disease also presented some degree
of fibrosis at US. However, in spite of its
wide utilization, some authors consider that
such purely quantitative analysis of peri-
portal thickening like the one utilized in US
protocol developed before the definition of
that of the Niamey Working Group (Abdel-
Wahab et al.(7)), for evaluation of chronic
schistosomal patients, has a low reproduc-
ibility(18,22,23). King et al.(24), utilizing the
Niamey protocol with 3,954 individuals in
Egypt and Kenya, have equally concluded
that the association of imaging patterns,
rather than the thickness of periportal
spaces isolatedly, seemed to represent a
more efficient method to classify the mor-
bidity and risk for digestive bleeding of the
disease.
As regards the group of non-hepato-
splenic individuals with fibrosis at US, it
was observed grades of fibrosis may be
found only in patients with the hepatoin-
testinal form of the disease, as reported by
previous studies(25,26). Other study suggests
that strictly central periportal thickening at
US, with no sign of portal hypertension,
may be the result of fat tissue deposition
around the portal vein(18). In this cases, US
must be supplemented by magnetic reso-
nance imaging(22).
Direct and statistically significant cor-
relations were observed between portal
vein diameter, spleen size and measure of
the right hepatic lobe in HS-HU patients,
as well as portal vein diameter, measure of
periportal space and size of the right he-
patic lobe in patients from the endemic area
(Table 2). It is known that the asymmetry
of the hepatic lobes observed at US in
chronic schistosomal patients with the
hepatosplenic form of the disease, enlarge-
ment of the left lobe and reduction of the
right lobe observed in up to 81% of the
cases(27), may be associated with a greater
blood flow towards the left lobe(28), besides
findings of splenomegaly, periportal and
perivesicular  thickening, increased caliber
of portal, splenic and superior mesenteric
veins, and identification of collateral
venous circulation(29–31). According to
Abdel-Wahab et al.(7) splenomegaly, portal
and splenic veins caliber, presence of col-
lateral circulation, and the number and size
of esophageal varices seen at endoscopy,
are also related to the intensity of peripor-
tal fibrosis(5). De Jesus et al.(l4), studying
individuals from another schistosomiasis
endemic area, have also found significant
direct correlation between the intensity of
periportal fibrosis and spleen size and por-
tal and splenic veins caliber, besides cor-
relation between the diameters of the por-
tal and splenic veins and spleen size.
In the present study, the low rate of de-
tection of periportal fibrosis in hepato-
splenic individuals from the endemic area
may also indicate, among other previously
mentioned factors, that such individuals
present with a lesser degree of schistoso-
mal hepatic lesions because of genetic or
regional differences, which are aspects that
deserve further analysis. Alternatively, such
data may reflect a low US capability to
detect periportal fibrosis at early stages of
Table 2 Correlations between sonographic parameters in individuals with chronic forms of schistosomiasis mansoni: hepatosplenic individuals from tertiary
institution (HS-HU) and patients with clinical chronic forms from the endemic areas.
Correlated sonographic parameters
Portal vein diameter and spleen size
Portal vein diameter and right hepatic lobe
Portal vein diameter and right hepatic lobe
Portal vein diameter and periportal space measurement
Group of patients
HS-HU
HS-HU
Endemic area
Endemic area
Number
of pairs XY
20
20
69
69
r Spearman
0.61
0.57
0.30
0.35
CI 95%
0.19–0.84
0.14–0.82
0.06–0.50
0.12–0.55
p value
0.01
0.01
0.01
0.003
CI, confidence interval.
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disease. Such data reinforce the utilization
of the Niamey classification adopted by
WHO for the detection of fibrosis at more
advanced stages of schistosomiasis, be-
sides calling attention to the complexity in
detecting lesions at early stages by US,
which highlights the major role of gado-
linium-enhanced magnetic resonance im-
aging as a supplementary diagnostic tool in
such cases, considering the high accuracy
of this method.
CONCLUSIONS
The Niamey protocol for US proposed
by the WHO detects advanced periportal
fibrosis in patients with severe disease,
with higher sensitivity than the isolate
measurement of the periportal space. How-
ever, the complexity involved in the iden-
tification of early stages of periportal fibro-
sis in endemic areas by US calls the atten-
tion to the role of a supplementary diagno-
sis and to the continued improvement of
US protocols in these areas.
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